Research article · 2020
Conference abstractPublished 6 Dec 2011
Current treatment of infantile hemangiomas
University Children’s Hospital Rijeka, Croatia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Infantile hemangiomas (IHs) are benign vascular tumors that have characteristic clinical course marked by early proliferation and followed by spontaneous involution. Th ey are the most common tumors of childhood. Th e heterogeneity of IHs makes it diffi cult to predict need for treatment and has made it challenging to establish a standardized approach to the management. Th e vast majority of these tumors do not require any surgical or medical intervention. Despite benign and self-limited nature, some IHs cause complications such as bleeding, ulceration, infection, and functional and cosmetic disability. In addition, they may compromise vital organ functions. Rarely, IHs may be associated with one or more underlying congenital anomalies. Treatments for IHs include topical, intralesional, and systemic therapies. Laser and surgical modalities are also sometimes used depending on the clinical course. Pharmacological therapy has been limited to a few medications. Steroids have remained the fi rst-line therapy for problematic IHs for over 40 years despite their known side eff ects. Vincristine has emerged as an alternative to interferon for steroid-resistant IHs because of signifi cant interferon’s adverse events, especially neurotoxicity. During the past few years, beta-adrenergic blockers have become the preferred fi rst-line therapy for problematic IHs in many centers. Th e recent discovery of the role of stem cells and of the renin-angiotensin system in the biology of IHs underscores the possibility of more targeted therapies. Education of parents about the natural history, prognosis, benefi ts and complications of potential treatment is important aspect of the management of IHs.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 11 Jul 2016
Oral itraconazole for treatment of infantile hemangiomas: Case series and mechanism research
Editorial · 2013
Reconsidering the Use of Propranolol in the Treatment of Cosmetic Infantile Hemangiomas
Conference abstract · 6 Dec 2011
Current treatment of infantile hemangiomas
Article · 26 Jun 2024
Infantile Hemangiomas: From Pathogenesis to Personalized Care
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Positive outcome in a patient with hypoplastic left heart syndrome: Key factors for successful survival: A case report
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Jelena Roganovic”

